key: cord-0864654-y2b040z0
authors: Cruz, Ana Fernández; Ruiz-Antorán, Belén; Múñez Rubio, Elena; López, Aránzazu Sancho; Callejas Díaz, Alejandro; Avendaño-Solá, Cristina; Martínez, Antonio Ramos
title: THE RIGHT TIME FOR STEROIDS IN COVID-19
date: 2020-06-25
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa865
sha: ee4555b9e3823b5187177b288f110de0bd6c1137
doc_id: 864654
cord_uid: y2b040z0

nan

M a n u s c r i p t Based on these considerations, we suggest that, in future studies evaluating the effect of immunomodulatory drugs in COVID-19, the moment of the onset of symptoms should be considered the reference time for the start of the study drug.

None of the authors has conflicts of interest

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

A c c e p t e d M a n u s c r i p t